ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 170 filers reported holding ANTARES PHARMA INC in Q3 2021. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $7,551,000 | +19.0% | 1,841,590 | +3.6% | 0.01% | +22.2% |
| Q4 2021 | $6,348,000 | -0.5% | 1,778,277 | +1.5% | 0.01% | -10.0% |
| Q3 2021 | $6,378,000 | -15.3% | 1,752,151 | +1.5% | 0.01% | -16.7% |
| Q2 2021 | $7,528,000 | +6.4% | 1,726,622 | +0.3% | 0.01% | 0.0% |
| Q1 2021 | $7,076,000 | +121.9% | 1,721,527 | +115.4% | 0.01% | +100.0% |
| Q4 2020 | $3,189,000 | +46.8% | 799,127 | -0.7% | 0.01% | +50.0% |
| Q3 2020 | $2,172,000 | -1.8% | 804,554 | 0.0% | 0.00% | -20.0% |
| Q2 2020 | $2,212,000 | +51.6% | 804,554 | +30.1% | 0.01% | +25.0% |
| Q1 2020 | $1,459,000 | -49.9% | 618,180 | -0.3% | 0.00% | -33.3% |
| Q4 2019 | $2,913,000 | +52.3% | 619,810 | +8.4% | 0.01% | +50.0% |
| Q3 2019 | $1,913,000 | +1.9% | 571,930 | +0.2% | 0.00% | 0.0% |
| Q2 2019 | $1,877,000 | +8.9% | 570,562 | +0.3% | 0.00% | 0.0% |
| Q1 2019 | $1,724,000 | +40.4% | 569,113 | -21.2% | 0.00% | +33.3% |
| Q3 2015 | $1,228,000 | -18.3% | 722,500 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $1,503,000 | -23.2% | 722,500 | 0.0% | 0.00% | -25.0% |
| Q1 2015 | $1,958,000 | +5.4% | 722,500 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $1,857,000 | +39.2% | 722,500 | -0.9% | 0.00% | +33.3% |
| Q3 2014 | $1,334,000 | -53.4% | 729,195 | -32.0% | 0.00% | -50.0% |
| Q2 2014 | $2,863,000 | -23.7% | 1,072,511 | +0.0% | 0.01% | -25.0% |
| Q1 2014 | $3,753,000 | +72.7% | 1,072,139 | +121.0% | 0.01% | +60.0% |
| Q4 2013 | $2,173,000 | – | 485,095 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|